PATTERN_AMBER_1320x780_2 Blogs
Read article A Closer Look at Immunophenotyping and its Applications at KCAS

Immunophenotyping has undergone a seismic change in less than two decades as panel sizes have increased in complexity from <10 to >40 colors. Let’s explore how immunophenotyping is transforming the field and how FlowMetric, a KCAS…

KCAS-blog-thumb_2023-07D_Flow-Expansion Blogs
Read article KCAS Bio Expands Flow Cytometry Services into Europe

In an exciting development, KCAS, through its subsidiary FlowMetric, is expanding its flow services in Europe. With a history of providing cutting-edge flow services in the EU, KCAS is taking a significant step forward by transitioning services from its Milan, Italy site to…

KCAS-blog-thumb_2023-07B_PK-ADCs Blogs
Read article Recent FDA Guidance for Pharmacokinetics and Antibody Drug Conjugates, and What They Mean for Your Projects at KCAS

With recent guidance released from the FDA, there are changes for PKs (Pharmacokinetics) and ADCs (Antibody Drug Conjugates) that must be clearly understood before making decisions for your drug product testing. ADCs combine the target specificity of monoclonal antibodies with the…

PATTERN_AMBER_1320x780_3 Blogs
Read article Expanding Spectral Flow Capabilities with Cytek Aurora

Spectral flow has come a long way in recent years, transforming from a mere whisper of possibility to an essential tool in bioanalysis. Initially gaining traction in academic institutions, it quickly caught the attention…

PATTERN_BLUE_1320x780 Blogs
Read article Overcoming Analytical Challenges in Oligonucleotide

In the world of scientific research and development, certain analytes pose unique challenges that require specialized expertise to overcome. Oligonucleotides, a class of analytes consisting of short DNA or RNA sequences, are notorious for their complexity and demanding nature. With their increasing importance in the…

PATTERN_BLUE_1320x780_2 Blogs
Read article FlowMetric and Cytek Partner on Flow Cytometry

Business Wire – May 24, 2023 11:00 AM EST – In an effort to continue…

KCAS-blog-thumb_2023_Navigating-Growth Blogs
Read article KCAS Growth: Navigating Company Expansion with Integrity and Engagement

Clinical research carries significant risks and numerous obstacles that must be overcome to achieve success. Identifying the ideal Contract…

KCAS-blog-thumb_2023-03_neuro-diseases Blogs
Read article Hope in motion: Monitoring Drug Efficacy for Neurodegenerative Diseases

Neurodegenerative diseases affect millions worldwide. Fifty million people are living with Alzheimer’s disease or other dementias. Although Alzheimer’s disease is one of the most recognized, it is just one of many neurological disorders, such as Multiple Sclerosis, Parkinson’s, or Huntington’s disease. These conditions lead to a…